Medifast (MED) Accumulated Depreciation & Amortization (2010 - 2025)

Medifast (MED) has 16 years of Accumulated Depreciation & Amortization data on file, last reported at $14.2 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 12.08% year-over-year to $14.2 million; the trailing twelve-month figure through Dec 2025 stood at $14.2 million (up 12.08% YoY), and the FY2025 full-year result was $14.2 million, up 12.08% from the prior year.
• Accumulated Depreciation & Amortization for Q4 2025 stood at $14.2 million, up from $12.7 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $14.2 million in Q4 2025 and bottomed at $6.8 million in Q4 2021.
• The 5-year median for Accumulated Depreciation & Amortization is $12.7 million (2024), against an average of $11.6 million.
• The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization surged 61.19%; it then dropped 3.05% in 2024.
• A 5-year view of Accumulated Depreciation & Amortization shows it stood at $6.8 million in 2021, then soared by 61.19% to $11.0 million in 2022, then gained by 19.37% to $13.1 million in 2023, then fell by 3.05% to $12.7 million in 2024, then grew by 12.08% to $14.2 million in 2025.
• The last three Accumulated Depreciation & Amortization figures came in at $14.2 million (Q4 2025), $12.7 million (Q4 2024), and $13.1 million (Q4 2023), per Business Quant data.

Peer Comparison